Waldencast to delist from Nasdaq, plans OTC trading under ‘MLKM’
Seeking Alpha News (Mon, 14-Sep 7:42 AM ET)
Waldencast to Delist from Nasdaq and Rebrand as Milk Makeup plc
TipRanks (Mon, 14-Sep 7:17 AM ET)
Globe Newswire (Mon, 14-Sep 6:55 AM ET)
Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
Globe Newswire (Thu, 30-Jul 4:30 PM ET)
Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
Globe Newswire (Mon, 15-Jun 9:00 AM ET)
Market Chameleon (Fri, 1-May 7:46 AM ET)
Market Chameleon (Thu, 30-Apr 7:10 AM ET)
Waldencast Announces SEC Investigation Conclusion: Favorable Outcome Signals Fresh Start
Market Chameleon (Wed, 29-Apr 5:54 AM ET)
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
Waldencast PLC - Class A Ordinary Share trades on the NASDAQ stock market under the symbol WALD.
As of September 14, 2026, WALD stock price declined to $1.16 with 2,159,214 million shares trading.
WALD has a beta of 0.42, meaning it tends to be less sensitive to market movements. WALD has a correlation of 0.00 to the broad based SPY ETF.
WALD has a market cap of $147.63 million. This is considered a Micro Cap stock.
Last quarter Waldencast PLC - Class A Ordinary Share reported $272 million in Revenue and -$2.01 earnings per share. This fell short of revenue expectation by $-14 million and missed earnings estimates by -$1.60.
In the last 3 years, WALD traded as high as $12.00 and as low as $.72.
WALD has underperformed the market in the last year with a price return of -35.2% while the SPY ETF gained +16.8%. WALD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -37.6% and -13.4%, respectively, while the SPY returned +3.4% and -1.1%, respectively.
WALD support price is $1.25 and resistance is $1.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WALD shares will trade within this expected range on the day.